Arena Pharmaceuticals posts narrower 4Q loss – Forbes
|
Arena Pharmaceuticals posts narrower 4Q loss
Forbes The drugmaker said it studied more than 7000 patients who were treated for up to two years, and subjects showed significant weight loss in both trials. … Arena will launch lorcaserin with partner or alone Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial … Arena Pharma Q4 Loss Narrows – Quick Facts |
View full post on weight loss – Google News
